Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DESIGN: Antiretroviral therapy (ART) currently represents the best way to avert the lethal consequences of chronic persistent HIV-1 infection. It leads to significant reductions of plasma viremia, often to undetectable levels, but it can also be linked with the reduction and disappearance of detectable HIV-specific CD8 T-cell responses. RESULTS: Here we describe a group of patients in whom ongoing replication of HIV, particularly transcription of Nef mRNA species, was detected despite prolonged and clinically successful antiretroviral treatment. Modest, but significant, numbers of HIV-specific CD8 T cells and CD4 T-cell responses were found in these subjects, with the strongest responses directed towards Nef epitopes. Detailed phenotypic analysis of the HIV-specific CD8 cells demonstrated low perforin levels and persistent expression of CD27, a phenotype associated with incomplete differentiation of cytotoxic T lymphocytes (CTL). CONCLUSION: This immature CTL phenotype has been described previously in association with chronic HIV disease, but its continued persistence is surprising in the setting of prolonged viral suppression on therapy and the presence of HIV-specific CD4 cell activity.


Journal article



Publication Date





161 - 170


Anti-HIV Agents, Antiretroviral Therapy, Highly Active, CD28 Antigens, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cohort Studies, HIV Antigens, HIV Infections, HIV Protease Inhibitors, HIV-1, Humans, Immunophenotyping, Indinavir, Interferon-gamma, Lamivudine, Membrane Glycoproteins, Palatine Tonsil, Perforin, Pore Forming Cytotoxic Proteins, RNA, Viral, Reverse Transcriptase Inhibitors, Time Factors, Treatment Outcome